论文部分内容阅读
目的:通过检测糖化血红蛋白(HbA1c)检测结果,来探讨其在糖尿病微血管病变的临床评估中的价值。方法:观察组100例患者,均来自我院就诊并确诊的病人,根据微血管病变组和无微血管病变组,对照组50例健康体检人员。所有入组人员均检测空腹血糖(FBG)和和血红蛋白(HbA1c。。对三组检测的结果进行分析比较。结果:观察组的的HbA1c和FBG明显高于对照组,差异有统计学意义(P<0.01);且有微血管病变患者明显高于无微血管病变患者。结论:此法可作为糖尿病微血管病变早期诊断依据,推荐在临床应用。
Objective: To investigate the value of HbA1c in the clinical evaluation of diabetic microangiopathy. Methods: The observation group of 100 patients were from our hospital for diagnosis and treatment of patients, according to microvascular disease group and no microvascular disease group, the control group of 50 health examination staff. The results of all the three groups were compared and analyzed.Results: The HbA1c and FBG in the observation group were significantly higher than those in the control group (P <0.01), and patients with microvascular disease were significantly higher than those without microvascular disease.Conclusion: This method can be used as an early diagnosis basis of diabetic microangiopathy, and is recommended for clinical application.